EGFR-targeting antitumor therapy: Neuregulins or antibodies?
de Lavera I, Merkling PJ, Oliva JM, Sayagués MJ, Cotán D, Sánchez-Alcázar JA, Infante JJ, Zaderenko AP.
de Lavera I, et al. Among authors: infante jj.
Eur J Pharm Sci. 2021 Mar 1;158:105678. doi: 10.1016/j.ejps.2020.105678. Epub 2020 Dec 16.
Eur J Pharm Sci. 2021.
PMID: 33340635
Free article.